Targeted therapy in sarcomas: mammalian target of rapamycin inhibitors from bench to bedside. [electronic resource]
- Expert opinion on investigational drugs Dec 2011
- 1685-705 p. digital
Publication Type: Journal Article; Review
1744-7658
10.1517/13543784.2011.628984 doi
Antibiotics, Antineoplastic--pharmacology Humans Molecular Targeted Therapy Protein Kinase Inhibitors--pharmacology Sarcoma--drug therapy Signal Transduction--drug effects Sirolimus--pharmacology TOR Serine-Threonine Kinases--antagonists & inhibitors Translational Research, Biomedical